Blog

HOW TO SELECT PHASE I CLINICAL RESEARCH UNIT FOR YOUR CLINICAL TRIAL

Selecting a Phase I clinical research unit requires careful consideration […]

CONVEX PHASE I TEAM PARTICIPATED ON SWISS BIOTECH DAY

On 24 – 25 April 2023 Convex CRO and a […]

FIRST-IN-MAN STUDY (SINGLE ASCENDING/MULTIPLE ASCENDING DOSE STUDY SAD/MAD)

First-In-Man study (single ascending/multiple ascending dose study SAD/MAD) and how […]

Biomarkers in Phase 1 Clinical Trials

Biomarkers in Phase 1 Clinical Trials- Drug Development Insights Imagine […]

Ethical Considerations in Phase 1 Trials

Phase 1 trials mark the frontier of medical research, offering […]

Phase 1 Clinical Trials: Safety and Efficacy Endpoints Explained

Unlocking the Secrets of Phase 1 Clinical Trials: Safety and […]

Phase1 Clinical Trials: Purpose, Scope, and Safety

Understanding Phase 1 Clinical Trials: Purpose, Scope, and Safety Phase […]

Safety Monitoring in Phase 1 Clinical Trials

Safety Monitoring in Phase 1 Clinical Trials: A Guide to […]

Regulatory Requirements for Phase 1 Clinical Trials

Regulatory Requirements for Phase 1 Clinical Trials When it comes […]

The Role of Healthy Volunteers in Phase 1 Clinical Trials

Why healthy volunteers rae the backbone of Phase 1 clinical […]

Design of Phase 1 Clinical Trials

Guide to Phase 1 Clinical Trials: Design, Protocols, and Patient […]